Questcor Pharmaceuticals Whiffs on Earnings

Questcor Pharmaceuticals (Nasdaq: QCOR  ) reported earnings on April 30. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended March 31 (Q1), Questcor Pharmaceuticals whiffed on revenues and whiffed on earnings per share.

Compared to the prior-year quarter, revenue expanded significantly. GAAP earnings per share increased.

Margins dropped across the board.

Revenue details
Questcor Pharmaceuticals notched revenue of $135.1 million. The 10 analysts polled by S&P Capital IQ predicted revenue of $157.7 million on the same basis. GAAP reported sales were 41% higher than the prior-year quarter's $96.0 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.65. The six earnings estimates compiled by S&P Capital IQ predicted $0.93 per share. GAAP EPS of $0.65 for Q1 were 12% higher than the prior-year quarter's $0.58 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 88.0%, 620 basis points worse than the prior-year quarter. Operating margin was 43.7%, much worse than the prior-year quarter. Net margin was 28.9%, much worse than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
Next quarter's average estimate for revenue is $173.0 million. On the bottom line, the average EPS estimate is $0.97.

Next year's average estimate for revenue is $675.1 million. The average EPS estimate is $3.62.

Investor sentiment
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 490 members out of 549 rating the stock outperform, and 59 members rating it underperform. Among 131 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 105 give Questcor Pharmaceuticals a green thumbs-up, and 26 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Questcor Pharmaceuticals is outperform, with an average price target of $45.38.

Can your portfolio provide you with enough income to last through retirement? You'll need more than Questcor Pharmaceuticals. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.

Add Questcor Pharmaceuticals to My Watchlist.